112 related articles for article (PubMed ID: 4302946)
1. [Hormonal changes and clinical effects produced in patients treated with a delyed-action preparation of synthetic ACTH].
Faglia G; Travanglini P; Norbiato G; Ambrosi B; Gattinoni L
Clin Ter; 1968 Jul; 46(1):23-44. PubMed ID: 4302946
[No Abstract] [Full Text] [Related]
2. Adrenal insufficiency in myasthenia gravis. A possible cause of adrenocorticotropic hormone (ACTH) treatment failure.
Cape CA
Bull Los Angeles Neurol Soc; 1972 Jul; 37(3):124-30. PubMed ID: 4339585
[No Abstract] [Full Text] [Related]
3. The determination of the urinary excretion of 11-oxy-17-ketosteroids in normal human individuals and in patients with rheumatoid arthritis.
Pal SB
Folia Endocrinol; 1967 Feb; 20(1):1-12. PubMed ID: 4294040
[No Abstract] [Full Text] [Related]
4. [Clinical tests of a new long-acting form of synthetic ACTH: Cortrosyn Depot].
Libon JC; Borlée J
Rev Med Liege; 1969 Nov; 24(21):762-5. PubMed ID: 4316477
[No Abstract] [Full Text] [Related]
5. [Adrenocorticotropic activity of a synthetic ACTH in humans].
Curreli A; Littarru G; Pinna E
Clin Ter; 1966 Oct; 39(2):115-22. PubMed ID: 4297549
[No Abstract] [Full Text] [Related]
6. [Diagnostic and therapeutic use of synthetic beta 1-24 corticotropin (30'920-BA Synacthen Ciba)].
Horký K; Küchel O
Vnitr Lek; 1968 Apr; 14(4):370-9. PubMed ID: 4298653
[No Abstract] [Full Text] [Related]
7. Corticotropin therapy in patients with myasthenia gravis: steroid metabolism, and histology of skeletal muscle and thymus.
Namba T; Shapiro MS
J Neurol Sci; 1972 Jun; 16(2):165-76. PubMed ID: 4338783
[No Abstract] [Full Text] [Related]
8. Response to metyrapone in children with rheumatic diseases.
Ruvalcaba RH; Waxman SH; Tippit DF; Kelley VC
J Pediatr; 1966 Feb; 68(2):257-64. PubMed ID: 4285955
[No Abstract] [Full Text] [Related]
9. [Synthetic ACTH therapy].
Uchiyama T; Ono M; Mikami T; Yagi H; Tei T
Horumon To Rinsho; 1973 Jul; 21(7):737-41. PubMed ID: 4358509
[No Abstract] [Full Text] [Related]
10. [Clinical and experimental testing of a new corticosteroid].
Radha E; Schönberg D; Bierich JR
Arzneimittelforschung; 1967 Sep; 17(9):1142-5. PubMed ID: 5632289
[No Abstract] [Full Text] [Related]
11. [Treatment of myasthenia with adrencorticotrophins (ACTH and Synacthen). Apropos of 100 treatments in 25 patients].
Goulon M; Nouailhat F; Barois A; Grosbuis S; Joron MH
Rev Neurol (Paris); 1972 Oct; 127(4):457-70. PubMed ID: 4355521
[No Abstract] [Full Text] [Related]
12. [Use of different types of ACTH in the evaluation of patients with hypophyseal tumors. Findings in 28 cases].
Artese R; Molocznik I; Guitelman A; Dickmann GH; Varela J; Schalit LG; Martinez Montes M
Prensa Med Argent; 1968 Sep; 55(30):1453-62. PubMed ID: 4303518
[No Abstract] [Full Text] [Related]
13. Myasthenia gravis treated with ACTH.
Day J
Nurs Times; 1967 Dec; 63(50):1695-6. PubMed ID: 4294739
[No Abstract] [Full Text] [Related]
14. Hormonal pattern in bronchial asthma (reversible obstructive lung disease). 1. Role of adrenal steroids.
Weller HH; Van der Straeten M; Vermeulen A; Orie NG
Scand J Respir Dis; 1968; 49(3):163-84. PubMed ID: 4309244
[No Abstract] [Full Text] [Related]
15. [Studies on the action duration of a new synthetic ACTH depot preparation].
Rausch-Stroomann JG; Petry R
Dtsch Med Wochenschr; 1968 Oct; 93(41):1938-41. PubMed ID: 4300470
[No Abstract] [Full Text] [Related]
16. [Response of the adrenal gland cortex to synthetic ACTH (30.920-Ba) in normal patients and those with endocrine disorders].
Schnitman DS; De Lapacó EK; Rozenfeld L
Rev Argent Endocrinol Metab; 1966 Dec; 12(4):244-54. PubMed ID: 4298849
[No Abstract] [Full Text] [Related]
17. [Disorders of the functional state of the adrenal cortex in precancerous diseases and cancer of the stomach].
Grokhovskii LP
Vopr Onkol; 1969; 15(11):33-8. PubMed ID: 4312834
[No Abstract] [Full Text] [Related]
18. ["Partial study of the corticoadrenal reserve in elderly patients"].
Gomez-Rojas RE; Froimovich J; Generini G; Lopez G
Rev Med Chil; 1967 Nov; 95(11):681-4. PubMed ID: 4302050
[No Abstract] [Full Text] [Related]
19. [Treatment with ACTH in the myasthenic syndrome with an immunological substratum].
Radu H; Roşu AM; Lenkei R; Ionescu V; Darko Z
Neurol Psihiatr Neurochir; 1973; 18(4):377-84. PubMed ID: 4356514
[No Abstract] [Full Text] [Related]
20. [Diagnostic value of serum ACTH in certain endocrine diseases].
Kolarov P; Tsanev A; Milanov St; Marovsk Sv; Balev R
Vutr Boles; 1973; 12(1):68-74. PubMed ID: 4351188
[No Abstract] [Full Text] [Related]
[Next] [New Search]
